NAGAI Hirokazu 永井宏和

… Alternative Names

永井宏和ナガイヒロカズ

Less

Researcher Number	30360811
Other IDs
Affiliation (Current)	2025: 独立行政法人国立病院機構(名古屋医療センター臨床研究センター), その他部局等, 部長
Affiliation (based on the past Project Information) *help	2012: 国立病院機構名古屋医療センター, 臨床研究センター, 部長 2012: 独立行政法人国立病院機構(名古屋医療センター臨床研究センター), その他部局等, その他 2012: 独立行政法人国立病院機構(名古屋医療センター臨床研究センター), 臨床研究センター, 部長 2011: 独立行政法人国立病院機構名古屋医療センター(臨床研究センター), 血液・腫瘍研究部, 部長 2010: 独立行政法人国立病院機構(名古屋医療センター臨床研究センター), 血液・腫瘍研究部, 部長 … More 2008: Clinical research Center, Nagoya National Hospital., 臨床研究センター, 血液・腫瘍研究部長 2008: Clinical research Center, Nagoya National Hospital., 血液・腫瘍研究部, 部長 2007: Clinical research Center, Nagoya National Hospital., 血液・腫瘍研究部, 部長 2005: National Hospital Organization, Nagoya Medical Center, Clinical Research Center, Department of Blood Disease Research, Chief, 血液造血器疾患研究部, 部長 2004: 独立行政法人国立病院機構名古屋医療センター(臨床研究センター), 血液造血器疾患研究部, 部長 Less
Review Section/Research Field	Principal Investigator Hematology Except Principal Investigator Hematology
Keywords	Principal Investigator p57KIP2遺伝子 / siRNA / p57KIP2 / DNAメチル化 / 癌抑制遺伝子 / 悪性リンパ腫 / tumor suppressor gene / B Cell lymphoma / cDNA microarray / DNA methylation … More / cDNA array / B細胞性リンパ腫 / cDNA micoroarray / 予後因子 / p57KI2遺伝子 / がん抑制遺伝子 / 予後予測因子 / 癌 / 癌遺伝子 / p57KIP遺伝子 / 微少残存病変 / p57KIP … More Except Principal Investigator 国際情報交流、米国 / 国際情報交換 / メタアナリシス / 比較効果研究 / 多発性骨髄腫 / 血液腫瘍学 Less

Comparative effectiveness research in first-line therapies for untreated multiple myeloma
- Principal Investigator
  
  TERASAWA Teruhiko
- Project Period (FY)
  2011 – 2012
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Hematology
- Research Institution
  Fujita Health University
p57KIP2 methylation as a prognostic biomarker of malignant lymphomaPrincipal Investigator
- Principal Investigator
  
  NAGAI Hirokazu
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  National Hospital Organization Nagoya Medical Center
The analysis of p57KIP2 gene in hematologic malignanciesPrincipal Investigator
- Principal Investigator
  
  永井宏和
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Clinical research Center, Nagoya National Hospital.
Analysis of p57KIP2 gene as tumor suppressor genePrincipal Investigator
- Principal Investigator
  
  NAGAI Hirokazu
- Project Period (FY)
  2004 – 2005
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  National Hospital Organization, Nagoya Medical Center, Clinical Research Center

All 2013 2012 2011 2010 2009 2008 2007 Other

All Journal Article Presentation Book

[Book] ホジキンリンパ腫 Cancer Treatment Navigator (中川和彦編)2008
- Author(s)
  永井宏和
- Publisher
  メディカルビュー社
- Data Source
  KAKENHI-PROJECT-19591150
[Journal Article] Prognosis of mature T cell lymphoma is poorer than that of diffuse large B cell lymphoma in IPI low-risk group, but not in intermediate- and high-risk groups.2013
- Author(s)
  Kihara R, Watanabe T, Yano T, Uike N, Okamura S, Kawano F, Hanada S, Sunami K, Inoue N, Sawamura M, Yoshida S, Shimomura T, Kitano K, Kojima Y, Horibe K, Nagai H
- Journal Title
  
  Int J Hematol.
  
  Volume: 98(1) Pages: 98-102
- Data Source
  KAKENHI-PROJECT-22591055
[Journal Article] Non-AIDS-defining hematological malignancies in HIV-infected patients : an epidemiological study in Japan.2013
- Author(s)
  Hagiwara S, Yotsumoto M, Odawara T, AjisawaA, Uehira T, Nagai H, Tanuma J, and Okada S
- Journal Title
  
  AIDS.
  
  Volume: 27(2) Pages: 279-283
- Data Source
  KAKENHI-PROJECT-22591055
[Journal Article] Clinical characteristics of humanimmunodeficiency virus-associated Hodgkin lymphoma patients in Japan.2012
- Author(s)
  Yotsumoto M, Hagiwara S, Ajisawa A, Tanuma J, Uehira T, Nagai H, Fujikawa Y, Maeda S, Kitano K, Arima N, Uno K, Iwai T, Hongo I, Ota Y, Fukutake K, and Okada S
- Journal Title
  
  Int J Hematol.
  
  Volume: 96(2) Pages: 247-53
- Data Source
  KAKENHI-PROJECT-22591055
[Journal Article] Phase I study of BCX1777 (forodesine) in patients with relapsed or refractory peripheral T/natural killer-cell malignancies.2012
- Author(s)
  Ogura M, Tsukasaki K, Nagai H, Uchida T, Oyama T, Suzuki T, Taguchi J, Maruyama D, Hotta T, Tobinai K
- Journal Title
  
  Cancer Sci.
  
  Volume: 103(7) Pages: 1290-5
- Data Source
  KAKENHI-PROJECT-22591055
[Journal Article] PROX1 overexpression inhibits protein kinase C beta II transcription through promoter DNA methylation.2012
- Author(s)
  Hagiwara K, Ito H, Murate T, Miyata Y, Ohashi H, and Nagai H
- Journal Title
  
  Genes Chromosomes Cancer.
  
  Volume: 51(11) Pages: 1024-1036
- Data Source
  KAKENHI-PROJECT-22591055
[Journal Article] Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma.2011
- Author(s)
  Nagai H, Ogura M, Kusumoto S, Takahashi N, Yamaguchi M, Takayama N, Kinoshita T, Motoji T, Ohyashiki K, Kosugi H, Matsuda S, Ohnishi K, Omachi K, Hotta T
- Journal Title
  
  Eur J Haematol.
  
  Volume: 86(2) Pages: 117-23
- Data Source
  KAKENHI-PROJECT-22591055
[Journal Article] IDEC-C2B8 Study Group. Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : a multicenter phase II study.2011
- Author(s)
  Tobinai K, Igarashi T, Itoh K, Kurosawa M, Nagai H, Hiraoka A, Kinoshita T, Uike N, Ogura M, Nawano S, Mori S, Ohashi Y
- Journal Title
  
  Cancer Sci.
  
  Volume: 102(9) Pages: 1698-705
- Data Source
  KAKENHI-PROJECT-22591055
[Journal Article] Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma2011
- Author(s)
  Nagai H.
- Journal Title
  
  Eur J Haematol
  
  Volume: 86 Pages: 117-123
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591055
[Journal Article] Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : a multicenter phase II study2011
- Author(s)
  Tobinai K, Nagai H
- Journal Title
  
  Cancer Sci
  
  Volume: 102 Issue: 9 Pages: 1698-1705
- DOI
  10.1111/j.1349-7006.2011.02001.x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591055
[Journal Article] Whole brain radiation alone produces favourable outcomes for AIDS-related primary central nervous system lymphoma in the HAART era2010
- Author(s)
  Nagai H.
- Journal Title
  
  Eur J Haematol
  
  Volume: 84 Pages: 499-505
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591055
[Journal Article] The Japanese Bendamustine Lymphoma Study Group. Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.2010
- Author(s)
  Ohmachi K, Ando K, Ogura M, Uchida T, Itoh K, Kubota N, Ishizawa K, Yamamoto J, Watanabe T, Uike N, Choi I, Terui Y, Usuki K, Nagai H, Uoshima N, Tobinai K
- Journal Title
  
  Cancer Sci.
  
  Volume: 101(9) Pages: 2059-64
- Data Source
  KAKENHI-PROJECT-22591055
[Journal Article] Whole brain radiation alone produces favourable outcomes for AIDS-related primary central nervous system lymphoma in the HAART era.2010
- Author(s)
  Nagai H, Odawara T, Ajisawa A, Hagiwara S, Watanabe T, Uehira T, Uchiumi H, Yotsumoto M, Miyakawa T, Watanabe A, Kambe T, Konishi M, Saito S, Takahama S, Tateyama M, Okada S
- Journal Title
  
  Eur J Haematol.
  
  Volume: 84(6) Pages: 499-505
- Data Source
  KAKENHI-PROJECT-22591055
[Journal Article] Ocular adnexal marginal zone B cell lymphoma infiltrated by IgG4-positive plasma cells.2010
- Author(s)
  Kubota T, Moritani S, Yoshino T, Nagai H, Terasaki H
- Journal Title
  
  J Clin Pathol.
  
  Volume: 63(12) Pages: 1059-65
- Data Source
  KAKENHI-PROJECT-22591055
[Journal Article] Fluorint-18-Fluorodeoxyglucose Positron Emission Tomography for Interim Response Assessment of Advanced-Stage Hodgkin's Lymphoma and DiffuseLarge B-cell Lymphoma : A Systematic Review2009
- Author(s)
  Terasawa T, Lau J, Bardet S, Couturier O, Hotta T, Hutchings M, Nihashi T, Nagai H
- Journal Title
  
  J Clin Oncol. 27
  
  Pages: 1906-1914
- Data Source
  KAKENHI-PROJECT-19591150
[Journal Article] ホジキンリンパ腫がん薬物療法学-基礎・臨床研究のアップデート-2009
- Author(s)
  永井宏和
- Journal Title
  
  日本臨床 67
  
  Pages: 764-770
- Data Source
  KAKENHI-PROJECT-19591150
[Journal Article] Remissi on induction therapy containing rituxi mab markedly improved the outcome of untreated mature B cell lymphoma British2008
- Author(s)
  Nagai H, Yano T, Watanabe T, Uike N, Okamura S, Hanada S, Kawano F, Sunami K, Inoue N, Sawamura M, Nishiura T, Hotta T, Honbe H
- Journal Title
  
  J Haematol 143
  
  Pages: 672-680
- Data Source
  KAKENHI-PROJECT-19591150
[Journal Article] Ocular adnexal mucosa-associated lymphoid tissue lymphoma with polyclonal hypergammagl obulinemia2008
- Author(s)
  Kubota T, Moritani S, Yoshino T, Nagai H, Terasaki H
- Journal Title
  
  Am J Ophthalmol 145
  
  Pages: 1002-1006
- Data Source
  KAKENHI-PROJECT-19591150
[Journal Article] 低悪性度B細胞性リンパ腫に対する標準的治療戦略2008
- Author(s)
  永井宏和
- Journal Title
  
  血液・腫瘍科 56
  
  Pages: 1-6
- Data Source
  KAKENHI-PROJECT-19591150
[Journal Article] 再発または難治性多発性骨髄腫におけるレナリドマイドの役割2008
- Author(s)
  永井宏和
- Journal Title
  
  医薬ジャーナル 44
  
  Pages: 113-118
- Data Source
  KAKENHI-PROJECT-19591150
[Journal Article] Actual status of AIDS-related lymphoma management in Japan2008
- Author(s)
  Hirokazu Nagai
- Journal Title
  
  Int J Hematol. 87
  
  Pages: 442-443
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591150
[Journal Article] Remission induction therapy containing rituximab markedly improved the outcome of untreated mature B cell lymphoma2008
- Author(s)
  Hirokazu Nagai
- Journal Title
  
  Br J Haematol 143
  
  Pages: 672-680
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591150
[Journal Article] Fluorine-18-fluorodeoxyglucose positron emission tomography for pos t-therapy assessment of Hodgkin's lymphoma and aggressive non-Hodgkin's lymphpoma2008
- Author(s)
  Terazawa T, Nihashi T, Hotta T, Nagai H
- Journal Title
  
  J Nucl Med 49
  
  Pages: 13-21
- Data Source
  KAKENHI-PROJECT-19591150
[Journal Article] 濾胞性リンパ腫-悪性リンパ腫update in 20082008
- Author(s)
  永井宏和
- Journal Title
  
  内科 102
  
  Pages: 293-299
- Data Source
  KAKENHI-PROJECT-19591150
[Journal Article] がん診療の最前線-ホジキンリンパ腫-2007
- Author(s)
  永井宏和
- Journal Title
  
  最新医学 67
  
  Pages: 1329-1340
- Data Source
  KAKENHI-PROJECT-19591150
[Journal Article] 造血器腫瘍-基礎・臨床領域における最新の研究動向-病因・病態解析-最近の展開-悪性リンパ腫2007
- Author(s)
  永井宏和
- Journal Title
  
  日本臨床 65(suppl 1)
  
  Pages: 80-85
- Data Source
  KAKENHI-PROJECT-19591150
[Journal Article] Frequent DNA methylation but no mutation of ID4 gene in malignant Iymohoma2007
- Author(s)
  Hagiwara K, Nagai H, Li Y, Ohashi H, Hotta T, Saito H
- Journal Title
  
  J Clin Exp Hematopathol 47
  
  Pages: 15-18
- Data Source
  KAKENHI-PROJECT-19591150
[Journal Article] 単一施設におけるHLA不一致 NIMA(non-inherited maternal antigen)相補的血縁間造血幹細胞移植13例の検討2007
- Author(s)
  濱口元洋, 加藤千明, 横澤敏也, 寺澤晃彦, 鈴木伸明, 青木恵津子, 大橋春彦, 永井宏和
- Journal Title
  
  日本輸血細胞治療学会誌 53
  
  Pages: 591-597
- Data Source
  KAKENHI-PROJECT-19591150
[Journal Article] 濾胞性リンパ腫に対するリツキシマブの維持療法2007
- Author(s)
  永井宏和
- Journal Title
  
  血液・腫瘍科 54
  
  Pages: 732-736
- NAID
  40019068115
- Data Source
  KAKENHI-PROJECT-19591150
[Journal Article] エイズ関連リンパ腫の現状と治療戦略
- Author(s)
  岡田誠治, 永井宏和, 味沢篤
- Journal Title
  
  臨床血液 49
  
  Pages: 206-214
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] 血液腫瘍細胞に対するベンダマスチンとキナーゼ阻害剤併用による殺細胞效果の検討2012
- Author(s)
  萩原和美, 宮田泰彦, 永井宏和
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-22591055
[Presentation] Cytotoxicity of bendamustine combined with new gereration kinase inhibitors in lymphoid cell lines.2012
- Author(s)
  Hagiwara K, Miyata Y, Nagai H.
- Organizer
  第74回日本血液学会学術集会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-22591055
[Presentation] Poorer prognosis of T/NK cell lymphoma than diffuse large B cell lymphoma in IPI low risk group contributes the unfavorable clinical outcome of T/NK cell lymphoma in clinical practice2011
- Author(s)
  Hirokazu Nagai
- Organizer
  11^<th> international conference on malignant lymphoma
- Place of Presentation
  Lugano, Switzerland
- Data Source
  KAKENHI-PROJECT-22591055
[Presentation] 癌抑制遺伝子としてのPROX1の機能解析2011
- Author(s)
  萩原和美、村手隆、宮田泰彦、堀田知光、永井宏和
- Organizer
  第73回日本血液学会学術集会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-22591055
[Presentation] The mechanisms of tumor suppression by PR0X12011
- Author(s)
  Hagiwara K, Murate T, Miyata Y, Hotta T, Nagai H.
- Organizer
  第7回日本癌学会学術総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-22591055
[Presentation] Prox1 suppressed tumor cell growth by the down regulation of PKCbII through the DNA methylation2011
- Author(s)
  Kazumi Hagiwara, Hirokazu Nagai
- Organizer
  53^<rd> American Society of Hammatology
- Place of Presentation
  San Diego USA
- Data Source
  KAKENHI-PROJECT-22591055
[Presentation] Rituxiamb Did Not Improve Clinical Outcomes In AIDS Related Burkitt Lymphoma2011
- Author(s)
  Hideyuki Yamamoto, Hirokazu Nagai
- Organizer
  53^<rd> American Society of Hammatology
- Place of Presentation
  San Diego USA
- Data Source
  KAKENHI-PROJECT-22591055
[Presentation] 濾胞性リンパ腫-治療選択のポイント2010
- Author(s)
  永井宏和
- Organizer
  第72回日本血液学会学術集会
- Place of Presentation
  横浜
- Year and Date
  2010-09-24
- Data Source
  KAKENHI-PROJECT-22591055
[Presentation] Increased Peripheral T Cell Response to EBV-Infected Cells with Frequent Detection of EBV-DNA In Plasma and Viral mRNA In Peripheral B-Cells In Immunocompetent EBV-Positive Diffuse Large B-Cell Lymphoma Patients.2010
- Author(s)
  Morisima S, Yamamoto K, Kimura H, Iwata S, Kinoshita T, Nagai H, Sugiura I, Tsushita K, Kagami Y, Miyamura K, Kuzushima K, Nakamura S, Morishima Y.
- Organizer
  52th Annual Meeting of the American Society of Hematology
- Place of Presentation
  Orland, USA
- Data Source
  KAKENHI-PROJECT-22591055
[Presentation] Poorer prognosis of intermediate BL/DLBCL compared to Burkitt lymphoma in rituximab era : A retrospective analysis with clinical and pathological features.2010
- Author(s)
  Nagai H
- Organizer
  15th Congress of European Hematology Association
- Place of Presentation
  Barcelona
- Year and Date
  2010-06-10
- Data Source
  KAKENHI-PROJECT-22591055
[Presentation] p57KIP2 gene methylation is useful to detect minimal residual disease in diffuse large B cell lymphoma2008
- Author(s)
  Nagai H, Hagiwara K, Hamaguchi M, Hotta T
- Organizer
  10^<th> Iinternational Congress on Malignant Iymphoma
- Place of Presentation
  Lugano Switzerland
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] AILTと診断されたMTX関連リンパ増殖症(MTX-LPD)の1例2008
- Author(s)
  萩原彰人, 森谷鈴子, 鈴木康裕, 青木恵津子, 加藤千明, 横澤敏也, 大橋春彦, 堀田知光, 市原周, 濱口元洋, 永井宏和
- Organizer
  第48回日本リンパ網内系学会総会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] p57KIP2 gene methylation is useful to detect minimal residual disease in diffuse large B cell lymphoma2008
- Author(s)
  Hirokazu Nagai
- Organizer
  10^<th> Iinternational Congress on Malignant lymphoma
- Place of Presentation
  Lugano, Switzerland
- Year and Date
  2008-06-04
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] 癌抑制遺伝子としてのPROX1の機能解析2008
- Author(s)
  萩原和美, 小栗佳代子, 堀田知光, 永井宏和
- Organizer
  第70回日本血液学会総会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] 末梢血幹細胞移植の今日的課題、臨床応用の現況と将来悪性リンパ腫(シンポジウム)2008
- Author(s)
  永井宏和
- Organizer
  第52回日本輸血・細胞治療学会東海支部例会
- Place of Presentation
  名古屋
- Year and Date
  2008-10-25
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] 悪性リンパ腫の臨床-エイズリンパ腫と非エイズリンパ腫(シンポジウム)2008
- Author(s)
  永井宏和
- Organizer
  第22回日本エイズ学会学術集会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] 多施設共同臨床試験併合解析による末梢T/NK細胞性リンパ腫の新たな予後予測モデル(JCOGO108A)2008
- Author(s)
  塚崎邦宏, 渡辺隆, 吉村健一, 木下朝博, 鏡味良豊, 伊藤園明, 小椋美知則, 加藤晴美, 山口素子, 黒澤光俊, 笠井正晴, 飛内賢正, 鈴木孝世, 薄井紀子, 正木康史, 未岡栄三郎, 張高明, 永井宏和, 安藤潔, 大西一功, 畑裕之, 吉田功, 松田信, 前田嘉治, 向井清, 中村栄男, 大島孝一, 堀田知光, 下山正徳
- Organizer
  第70回日本血液学会総会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] 高齢者急性骨髄性白血病における救援化学療法としてのGemtuzumab Ozogamicin (GO)2008
- Author(s)
  鈴木康裕, 横澤敏也, 萩原彰人, 青木恵津子, 加藤千明, 大橋春彦, 堀田知光, 濱口元洋, 永井宏和
- Organizer
  第70回日本血液学会総会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] Remission induction therapy containing rituximab improved the outcome of untreated DLBCL especially at poor risk of R-IPI-a retrospective analysis2008
- Author(s)
  Hirokazu Nagai
- Organizer
  The 32^<th> World Congress of the International Society of Hematology
- Place of Presentation
  Bangkok, Thai
- Year and Date
  2008-10-19
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] 本邦でのAIDS-related lymphomaの診療実態調査2008
- Author(s)
  永井宏和, 岩崎奈美, 小田原隆, 岡田誠治
- Organizer
  第70回日本血液学会総会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] HIV陰性HHV-8陰性のprimary effusion lymphomaの一例2008
- Author(s)
  小島勇貴, 萩原彰人, 森谷鈴子, 鈴木康裕, 横澤敏也, 青木恵津子, 大橋春彦, 市原周, 溝口元洋, 堀田知光, 永井宏和
- Organizer
  第70回日本血液学会総会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] HAARTと強力化学療法を併用したAIDS関連Burkitt lymphoma/leukemiaの3例2008
- Author(s)
  萩原彰人, 鈴木康裕, 青木恵津子, 森谷鈴子, 間宮均人, 加藤千明, 横澤敏也, 大橋春彦, 堀田知光, 市原周, 濱口元洋, 永井宏和
- Organizer
  第70回日本血液学会総会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] B細胞性リンパ腫の治療成績の後方視的解析(リツキシマブ導入前後の比較)2007
- Author(s)
  永井宏和, 横澤敏也, 渡辺智之, 鵜池直邦, 岡村精一, 矢野尊啓, 花田修一, 河野文夫, 角南一貴, 池田弘和, 澤村守夫, 西浦哲雄, 堀田知光, 堀部敬三
- Organizer
  第69回日本血液学会・第49回日本臨床血液学会合同総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] Addition of rituximab improves progression-free and overall survival in patients with B-cell lymphoma receiving doxorubicin-containing chemotherapy2007
- Author(s)
  Sakiai T, Nagai H, Watanabe T, Uike N, Okamura S, Yano T, Kawano F, Hanada S, Sunami K, Ikeda H, Sawamura M, Nishiura T, Hotta T, Horibe K
- Organizer
  The 49^<th> annual meeting of American Society of hematology
- Place of Presentation
  Atlanta, USA
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] B細胞性リンパ腫に対する抗体療法の動向 : Rituximabによる濾胞性リンパ腫治療の進歩と最新の臨床試験成績2007
- Author(s)
  永井宏和
- Organizer
  第47回日本リンパ網内系学会総会
- Place of Presentation
  淡路
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] p57KIP2遺伝子のメチル化を指標としたB細胞性リンパ腫における微少残存病変の検出2007
- Author(s)
  萩原和美, 横澤敏也, 堀田知光, 永井宏和
- Organizer
  第54回日本臨床検査医学会学術集会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] 骨髄増殖性疾患患者の造血コロニーを対象としたJAK2/V617F変異とX染色体の不活化パターンの検討2007
- Author(s)
  大橋春彦, 深見晶子, 小栗佳代子, 永井宏和, 横澤敏也, 濱口元洋, 堀田知光
- Organizer
  第69回日本血液学会・第49回日本臨床血液学会合同総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] Detection of p57KIP2 gene methylation is useful maarker for minimal residual disease in diffuse large B cell lymphoma2007
- Author(s)
  Hagiwara K, Nagai H, Yokozawa T, Kato C, Hamaguchi M, Hotta T, Horibe K
- Organizer
  The 49^<th> annual meeting of American society of hematolog
- Place of Presentation
  Atlanta, USA
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] 当施設における高齢者急性骨髄性白血病の臨床的検討 : 単一施設での治療成績2007
- Author(s)
  鈴木康裕, 横澤敏也, 萩原彰人, 寺澤晃彦, 青木恵津子, 加藤千明, 大橋春彦, 永井宏和, 堀田知光, 濱口元洋
- Organizer
  第69回日本血液学会・第49回日本臨床血液学会合同総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-19591150
[Presentation] Proxl suppressed tumor cell growth by the down regulation of PKCbII through the DNA methylation
- Author(s)
  Hagiwara K, Murate T, Miyata Y, Hotta T, Nagai H.
- Organizer
  53^<rd> American Society of Hammatology
- Place of Presentation
  San Diego USA
- Data Source
  KAKENHI-PROJECT-22591055

1. TERASAWA Teruhiko (30399597)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

NAGAI Hirokazu 永井 宏和

永井 宏和 ナガイ ヒロカズ

Research Projects

Research Products

Co-Researchers

Comparative effectiveness research in first-line therapies for untreated multiple myeloma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

p57KIP2 methylation as a prognostic biomarker of malignant lymphomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The analysis of p57KIP2 gene in hematologic malignanciesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis of p57KIP2 gene as tumor suppressor genePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] ホジキンリンパ腫 Cancer Treatment Navigator (中川和彦編)2008

Author(s)

Publisher

Data Source

[Journal Article] Prognosis of mature T cell lymphoma is poorer than that of diffuse large B cell lymphoma in IPI low-risk group, but not in intermediate- and high-risk groups.2013

Author(s)

Journal Title

Data Source

[Journal Article] Non-AIDS-defining hematological malignancies in HIV-infected patients : an epidemiological study in Japan.2013

Author(s)

Journal Title

Data Source

[Journal Article] Clinical characteristics of humanimmunodeficiency virus-associated Hodgkin lymphoma patients in Japan.2012

Author(s)

Journal Title

Data Source

[Journal Article] Phase I study of BCX1777 (forodesine) in patients with relapsed or refractory peripheral T/natural killer-cell malignancies.2012

Author(s)

Journal Title

Data Source

[Journal Article] PROX1 overexpression inhibits protein kinase C beta II transcription through promoter DNA methylation.2012

Author(s)

Journal Title

Data Source

[Journal Article] Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma.2011

Author(s)

Journal Title

Data Source

[Journal Article] IDEC-C2B8 Study Group. Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : a multicenter phase II study.2011

Author(s)

Journal Title

Data Source

[Journal Article] Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma2011

Author(s)

Journal Title

Data Source

[Journal Article] Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : a multicenter phase II study2011

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Whole brain radiation alone produces favourable outcomes for AIDS-related primary central nervous system lymphoma in the HAART era2010

Author(s)

Journal Title

Data Source

[Journal Article] The Japanese Bendamustine Lymphoma Study Group. Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.2010

Author(s)

Journal Title

Data Source

[Journal Article] Whole brain radiation alone produces favourable outcomes for AIDS-related primary central nervous system lymphoma in the HAART era.2010

Author(s)

NAGAI Hirokazu 永井宏和

永井宏和ナガイヒロカズ

[Journal Article] ホジキンリンパ腫がん薬物療法学-基礎・臨床研究のアップデート-2009